Why the study?
Is the Arg1086His mutation in the CACNA1S gene associated with malignant hyperthermia susceptibility in a North American population?
Is the Arg1086His mutation in the CACNA1S gene associated with malignant hyperthermia susceptibility in a North American population?
The Arg1086His mutation in the CACNA1S gene is associated with malignant hyperthermia in a specific family and is present in approximately 1% of the North American malignant hyperthermia susceptible population.
Answers are grounded in this paper and cite their sources.
Arg1086His was associated with MHS in this North American family; leaves open its diagnostic role and prevalence pending larger validation studies.
Individuals from a large North American population were screened for the presence of the mutation in the alpha1 subunit of the voltage-dependent calcium channel (CACNA1S) that has recently been associated with malignant hyperthermia (MH). This Arg1086His mutation was screened for in 154 MH normal (MHN) individuals and 112 MH susceptible (MHS) individuals, who were diagnosed by the North American protocol of the in vitro contracture test. PCR and restriction enzyme analysis was used to test for the mutation. The Arg1086His mutation in the CACNA1S was not found in any of the MHN individuals. In contrast, two related individuals (grandfather and grandson, father and son of the MH proband) among the MHS group exhibited this mutation. However, a third MHS individual in the same family (granddaughter, cousin of the grandson) did not exhibit this mutation. These results indicate that this mutation may be associated with MH in this family. Genetic alterations in the CACNA1S associated with MH are present in approximately 1% of this North American MHS population.
No takes yet. Share an insight, caveat, or question.
Stewart et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: